25 Recruiting Non-Alcoholic Fatty Liver Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Non-Alcoholic Fatty Liver Disease Studies
The Olmsted NAFLD Epidemiology Study (TONES)
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
📍 ProSciento CRU — Chula Vista, California
View Study & Checklist ➔Fructose and Liver Diseases in Youth: Help Them FLY
📍 Clinical Research Unit, University of Alberta — Edmonton, Alberta
View Study & Checklist ➔A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
📍 GSK Investigational Site — Arcadia, California
View Study & Checklist ➔Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
📍 Ann & Robert H Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
📍 The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149) — Chandler, Arizona
View Study & Checklist ➔AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
📍 AdventHealth Translational Research Institute — Orlando, Florida
View Study & Checklist ➔A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
📍 GSK Investigational Site — Chandler, Arizona
View Study & Checklist ➔A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
📍 GSK Investigational Site — Rialto, California
View Study & Checklist ➔A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
📍 Central Research Associates — Birmingham, Alabama
View Study & Checklist ➔Quantifying Hepatic Mitochondrial Fluxes in Humans
📍 Texas Diabetes Institute - University Health System — San Antonio, Texas
View Study & Checklist ➔Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
📍 Ann & Robert H Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔Soluble Fibre Supplementation in NAFLD
📍 McMaster University Medical Center — Hamilton, Ontario
View Study & Checklist ➔Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD
📍 Institut sur la nutrition et les aliments fonctionnels (INAF) — Québec, Quebec
View Study & Checklist ➔